NIGP 11505: Biochemical Reagents and Tests: Antibiotic Assays, Differentiation Discs, etc.

NIGP 11505, Biochemical Reagents and Tests: Antibiotic Assays, Differentiation Discs, Etc., an Item code, encompasses diagnostic and screening reagents, controls, calibrators, and consumables used across clinical laboratories, public health laboratories, newborn screening programs, forensic DNA analysis, and correctional healthcare systems. State and local governments procure these supplies for pathogen detection, therapeutic drug monitoring, newborn genetic screening, HIV confirmation testing, and offender drug testing operations. Recent solicitations show substantial sole-source and non-competitive activity driven by FDA approvals, proprietary formulations, and internal validation requirements that narrow vendor options to single manufacturers or distributors.

Issuing bodies span state departments of health, state police, county health services and community supervision departments, public health laboratory bureaus, school districts, and special-purpose entities. Florida Department of Health Bureau of Public Health Laboratories, Utah Department of Health and Human Services, Mississippi Department of Mental Health, Oregon State Police, and Collin County (Texas) Community Supervision and Corrections Department appear as repeat active buyers. Geographic spread includes Florida, Utah, Mississippi, Oregon, Texas, Maryland, Georgia, California, and the District of Columbia. Representative recent opportunities include Florida Department of Health BPHL's single-source procurement of Sebia reagents, controls, calibrators, and services for the CAPILLARS 3 DBS newborn screening analyzer ($2.7 million over three years, posted May 13, 2026 with June 3 response deadline); Collin County Community Supervision and Corrections Department's RFP for offender specimen collection and drug testing services covering immunoassay screening and LC/MS/MS or GC/MS confirmation, estimated at $600,000 over two years (posted September 25, 2026); Utah Department of Health and Human Services' sole-source increase to existing Contract 226354 with Enfanos for substrates and internal standards in MPS-I and Pompe Disease newborn screening ($116,000 increase to $466,000 total, posted September 24, 2026); and San Bernardino County Department of Public Health's ITB for culture media, stains, reagents, antimicrobial susceptibility disks, and diagnostic materials (posted July 15, 2026 with July 31 bid deadline).